Chiesi is an Italian, family-owned company which also has a large number of employees in the UK.
Established in 1935, Chiesi concentrates primarily on developing respiratory, cardiovascular and neonatological drugs, in particular surfactant drugs used to help premature babies breathe.
Chiesi has been partnered with Bliss since early 2018 and since that that partnership began, it has offered educational bursaries to ten researchers in neonatal care to attend the European Academy of Paediatric Societies Congress in Paris and has also sponsored a study day for healthcare professionals in Manchester in November with another to be held in London early in 2019.
We are most grateful to Chiesi for their continued support.